Evidence map›Paper›PMID 36686260›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Modification of bacterial cells for

Iaroslav Rybkin, Sergey Pinyaev, Olga Sindeeva, Sergey German, Maja Koblar, Nikolay Pyataev, Miran Čeh, Dmitry Gorin, Gleb Sukhorukov, Aleš Lapanje

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Iaroslav RybkinHelmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.
Sergey PinyaevNational Research Ogerev Mordovia State University, Saransk, Russia.
Olga SindeevaState University, Saratov, Russia.
Sergey GermanCenter of Photonic Science and Engineering, Skolkovo Institute of Science and Technology, Moscow, Russia.
Maja KoblarJožef Stefan Institute, Ljubljana, Slovenia.
Nikolay PyataevNational Research Ogerev Mordovia State University, Saransk, Russia.
Miran ČehJožef Stefan Institute, Ljubljana, Slovenia.
Dmitry GorinCenter of Photonic Science and Engineering, Skolkovo Institute of Science and Technology, Moscow, Russia.
Gleb SukhorukovA.V. Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia.
Aleš LapanjeJožef Stefan Institute, Ljubljana, Slovenia.
Jožef Stefan Institute · SINational Research Mordovia State University · RUSkolkovo Institute of Science and Technology · RUInstitute of Spectroscopy · RUSaratov State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It was shown recently that bacterial strains, which can act specifically against malignant cells, can be used efficiently in cancer therapy. Many appropriate bacterial strains are either pathogenic or invasive and there is a substantial shortage of methods with which to monitor

Indexed as

bacterial therapycancer treatmentelectrostatic interactionencapsulationguiding of cellslayer-by-layer approachmagnetic fieldmodification of cell surface

Identifiers

PMID36686260
PMCPMC9845715
OpenAlexW4313493629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.